Quick Answer
Jazz Pharmaceuticals plc reported Long-Term Debt of $4.33 billion for fiscal year 2025.
Jazz Pharmaceuticals plc Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $4.33B | -28.8% |
| 2024 | $6.08B | +19.0% |
| 2023 | $5.11B | -10.3% |
| 2022 | $5.69B | -5.4% |
| 2021 | $6.02B | +225.6% |
| 2020 | $1.85B | +17.5% |
| 2019 | $1.57B | +0.7% |
| 2018 | $1.56B | +1.5% |
| 2017 | $1.54B | -22.7% |
| 2016 | $1.99B | +73.2% |
| 2015 | $1.15B | -13.7% |
| 2014 | $1.33B | +144.9% |
| 2013 | $544.40M | +27.5% |
| 2012 | $427.07M | — |
| 2011 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.33B | -28.8% | -0.1% |
| June 30, 2025 | $4.34B | -15.0% | -18.8% |
| March 31, 2025 | $5.34B | +4.5% | -12.2% |
| December 31, 2024 | $6.08B | +19.0% | -0.1% |
| September 30, 2024 | $6.08B | +19.0% | +19.2% |
| June 30, 2024 | $5.10B | -10.3% | -0.1% |
| March 31, 2024 | $5.11B | -10.3% | -0.1% |
| December 31, 2023 | $5.11B | -10.3% | -0.1% |
- Jazz Pharmaceuticals plc showed a decrease of -28.8% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from Jazz Pharmaceuticals plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: